<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0005471.ref017">
 <label>17</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Sabchareon</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Wallace</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Sirivichayakul</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Limkittikul</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Chanthavanich</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Suvannadabba</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial</article-title>. 
  <source>Lancet</source>. 
  <year>2012</year>;
  <volume>380</volume>(
  <issue>9853</issue>):
  <fpage>1559</fpage>â€“
  <lpage>67</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(12)61428-7</pub-id>
  <?supplied-pmid 22975340?>
  <pub-id pub-id-type="pmid">22975340</pub-id>
 </mixed-citation>
</ref>
